Supply Chain

Louisville, Colo.-based Global Healthcare Exchange polled 50 supply chain leaders from across the country on their main priorities and outcomes for the healthcare supply chain in 2017.

Deregulation could be the key to lowering high drug costs, said healthcare writer David Hogberg in an op-ed piece for the conservative publication The American Spectator.

Drugmakers and employers are hopeful that the GOP's plan to repeal the ACA will elimninate the Branded Prescription Drug Fee — an excise tax on brand name medications, reports The Hill.

Martin Shkreli, former CEO of Turing Pharmaceuticals, is targeting the drug industry with a new website highlighting the major issues of individual drugmakers, reports STAT News.

The Food and Drug Administration granted priority review designation for Roche's rheumatoid arthritis drug Actemra, reports Reuters.

The Food and Drug Administration recently approved a new indication for the drug Imbruvica.

President Donald Trump met with a group of Fortune 500 CEOs at the White House Monday and warned them that any move to shift manufacturing processes overseas will be met with a "substantial border tax," reports CNN.

The Florida Department of Health on Friday sent an email to pharmacists warning them of potential prescription drug shortages in the state due to recent sanctions taken against the wholesale drug distributor McKesson Corp., reports Pain News Network.

President Donald Trump signed an executive order Monday formally withdrawing the U.S. from the Trans-Pacific Partnership — a trade agreement to lower or eliminate tariffs between the U.S. and 11 other countries, reports NBC News.

The pharmaceutical industry's major lobbying group has launched its largest-ever ad campaign designed to improve the industry's public image following heated criticism over rising drug prices and President Donald Trump's comments in a January press conference, in which he said…